⌘K

Home/Filings/4/0001610618-21-000091

4//SEC Filing

Daruwala Paul 4

Accession 0001610618-21-000091

CIK 0001610618other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 9:27 PM ET

Size

4.8 KB

Accession

0001610618-21-000091

Insider Transaction Report

Form 4

Period: 2021-09-30

Cidara Therapeutics, Inc.CDTX

Chief Medical Officer

Transactions

Award
Common Stock
2021-09-30+132,000→ 182,531 total

Footnotes (1)

[F1]All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.

Documents

1 file

4
wf-form4_163339722797134.xmlPrimary
FORM 4

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1

filerCIK 0001639144

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 9:27 PM ET
Size: 4.8 KB

View on SEC.gov